Suvretta Capital Management, LLC Insmed Inc Transaction History

Suvretta Capital Management, LLC

$2.54 Billion
Q3 2024

A detailed history of Suvretta Capital Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 1,635,709 shares of INSM stock, worth $116 Million. This represents 4.7% of its overall portfolio holdings.

Number of Shares

1,635,709

Previous 2,521,800 35.14%

Holding current value

$116 Million

Previous $169 Million 29.33%

% of portfolio

4.7%

Previous 7.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $54.9 Million - $70 Million	-886,091 Reduced 35.14%	1,635,709 $119 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $11 Million - $34.8 Million	498,800 Added 24.66%	2,521,800 $169 Million
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $17 Million - $19.8 Million	-661,487 Reduced 24.64%	2,023,000 $54.9 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $17.8 Million - $24.2 Million	-761,847 Reduced 22.11%	2,684,487 $83.2 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $6.69 Million - $9.08 Million	337,000 Added 10.84%	3,446,334 $87 Million
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $2.91 Million - $3.74 Million	177,196 Added 6.04%	3,109,334 $65.6 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $6.69 Million - $8.94 Million	411,237 Added 16.31%	2,932,138 $50 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $21.9 Million - $29.9 Million	1,290,101 Added 104.82%	2,520,901 $50.4 Million
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $17.7 Million - $23.9 Million	-847,880 Reduced 40.79%	1,230,800 $26.5 Million
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $13 Million - $19.5 Million	760,248 Added 57.66%	2,078,680 $41 Million
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $4.84 Million - $6.66 Million	236,900 Added 21.9%	1,318,432 $31 Million
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $2.14 Million - $2.77 Million	82,800 Added 8.29%	1,081,532 $29.5 Million
Q3 2021 Nov 15, 2021	BUY	$22.46 - $29.47 $12.5 Million - $16.4 Million	557,667 Added 126.44%	998,732 $27.5 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $10.7 Million - $15.9 Million	441,065 New	441,065 $12.6 Million
Q1 2021 May 17, 2021	SELL	$32.28 - $44.3 $10.9 Million - $14.9 Million	-337,145 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$26.0 - $34.5 $14.5 Million - $19.3 Million	-558,415 Reduced 62.35%	337,145 $10.8 Million
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $11.7 Million - $24.4 Million	828,960 Added 1244.68%	895,560 $24.7 Million
Q1 2020 May 15, 2020	BUY	$13.63 - $33.98 $907,758 - $2.26 Million	66,600 New	66,600 $1.07 Million

Others Institutions Holding INSM

# of Institutions

466

Shares Held

180M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.57B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Account

Suvretta Capital Management, LLC Insmed Inc Transaction History